MedTrace Logo

Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias

NCT02303639 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-09-01

No results posted yet for this study

Summary

The study evaluates whether catheter based radiofrequency ablation is superior to optimized antiarrhythmic medical therapy in preventing ventricular tachyarrhythmia relapses in patients with ischemic heart disease and implantable cardioverter defibrillator.

Conditions

Interventions

PROCEDURE

Radiofrequency catheter ablation

Catheter ablation with an open-irrigated tip ablation catheter and 3D electroanatomical mapping

DRUG

Antiarrhythmic drug therapy

Amiodarone (or sotalol) for prevention of VT/VF relapses

Sponsors & Collaborators

  • Biosense Webster, Inc.

    collaborator INDUSTRY

  • Central Finland Hospital District

    lead OTHER

Principal Investigators

  • Pekka Raatikainen, MD PhD · Keski-Suomen sairaanhoitopiiri

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-06-30
Completion
2018-06-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02303639 on ClinicalTrials.gov